Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis

Autores
Blanchard, Benoit; Heurtaux, Tony; Garcia, Corina Ileana; Moll, Natalia M.; Caillava, Céline; Grandbarbe, Luc; Klosptein, Armelle; Kerninon, Christophe; Frah, Magali; Coowar, Djalil; Baron-van Evercooren, Anne; Morga, Eleonora; Heuschling, Paul; Nait Oumesmar, Brahim
Año de publicación
2013
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Multiple sclerosis (MS) is an inflammatory disease of the CNS that is associated with demyelination and axonal loss, resulting in severe neurological handicap. Current MS therapies mostly target neuroinflammation but have only a little impact on CNS myelin repair. Progress toward treatments that enhance remyelination would therefore represent major advances in MS treatment. Here, we examined the ability of TFA-12, a new synthetic compound belonging to tocopherol long-chain fatty alcohols, to promote oligodendrocyte regeneration and remyelination in experimental models of MS. We showed that TFA-12 significantly ameliorates neurological deficit and severity of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE) in mice. Histological evaluation of mouse EAE spinal cords showed that TFA-12 treatment reduces inflammation, astrogliosis, and myelin loss. Additionally, we demonstrated that TFA-12 accelerates remyelination of focal demyelinated lesions induced by lysolecithin injections.Wealso found that this compound induces the differentiation of oligodendrocyte precursor cells into mature oligodendrocytes through the inhibition of the Notch/Jagged1 signaling pathway. Altogether, our data provide important proof of principle indicating that TFA-12 could be a potential therapeutic compound for myelin repair in MS.
Fil: Blanchard, Benoit. Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia; . Institut National de la Santé et de la Recherche Médicale; Francia
Fil: Heurtaux, Tony. Université du Luxembourg. Faculté des Sciences, de la Technologie et de la Communication. Laboratoire de Neurobiologie. Life Sciences Research Unit; Luxemburgo;
Fil: Garcia, Corina Ileana. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Farmacología. Cátedra de Química Medicinal; Argentina. Institut National de la Santé et de la Recherche Médicale; Francia. Universite Pierre et Marie Curie; Francia;
Fil: Moll, Natalia M.. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;
Fil: Caillava, Céline. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;
Fil: Grandbarbe, Luc. Université du Luxembourg. Faculté des Sciences, de la Technologie et de la Communication. Laboratoire de Neurobiologie. Life Sciences Research Unit; Luxemburgo;
Fil: Klosptein, Armelle. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;
Fil: Kerninon, Christophe. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;
Fil: Frah, Magali. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;
Fil: Coowar, Djalil. AxoGlia Therapeutics; Luxemburgo;
Fil: Baron-van Evercooren, Anne. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;
Fil: Morga, Eleonora. Université du Luxembourg. Faculté des Sciences, de la Technologie et de la Communication. Laboratoire de Neurobiologie. Life Sciences Research Unit; Luxemburgo;
Fil: Heuschling, Paul. Université du Luxembourg. Faculté des Sciences, de la Technologie et de la Communication. Laboratoire de Neurobiologie. Life Sciences Research Unit; Luxemburgo;
Fil: Nait Oumesmar, Brahim. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;
Materia
Tfa-12
Oligodendrocytes
Multiple Sclerosis
Myelin
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/1723

id CONICETDig_bb14c22a859caaea1a03cee8fa3bbd33
oai_identifier_str oai:ri.conicet.gov.ar:11336/1723
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple SclerosisBlanchard, BenoitHeurtaux, TonyGarcia, Corina IleanaMoll, Natalia M.Caillava, CélineGrandbarbe, LucKlosptein, ArmelleKerninon, ChristopheFrah, MagaliCoowar, DjalilBaron-van Evercooren, AnneMorga, EleonoraHeuschling, PaulNait Oumesmar, BrahimTfa-12OligodendrocytesMultiple SclerosisMyelinhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3https://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Multiple sclerosis (MS) is an inflammatory disease of the CNS that is associated with demyelination and axonal loss, resulting in severe neurological handicap. Current MS therapies mostly target neuroinflammation but have only a little impact on CNS myelin repair. Progress toward treatments that enhance remyelination would therefore represent major advances in MS treatment. Here, we examined the ability of TFA-12, a new synthetic compound belonging to tocopherol long-chain fatty alcohols, to promote oligodendrocyte regeneration and remyelination in experimental models of MS. We showed that TFA-12 significantly ameliorates neurological deficit and severity of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE) in mice. Histological evaluation of mouse EAE spinal cords showed that TFA-12 treatment reduces inflammation, astrogliosis, and myelin loss. Additionally, we demonstrated that TFA-12 accelerates remyelination of focal demyelinated lesions induced by lysolecithin injections.Wealso found that this compound induces the differentiation of oligodendrocyte precursor cells into mature oligodendrocytes through the inhibition of the Notch/Jagged1 signaling pathway. Altogether, our data provide important proof of principle indicating that TFA-12 could be a potential therapeutic compound for myelin repair in MS.Fil: Blanchard, Benoit. Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia; . Institut National de la Santé et de la Recherche Médicale; FranciaFil: Heurtaux, Tony. Université du Luxembourg. Faculté des Sciences, de la Technologie et de la Communication. Laboratoire de Neurobiologie. Life Sciences Research Unit; Luxemburgo;Fil: Garcia, Corina Ileana. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Farmacología. Cátedra de Química Medicinal; Argentina. Institut National de la Santé et de la Recherche Médicale; Francia. Universite Pierre et Marie Curie; Francia;Fil: Moll, Natalia M.. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;Fil: Caillava, Céline. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;Fil: Grandbarbe, Luc. Université du Luxembourg. Faculté des Sciences, de la Technologie et de la Communication. Laboratoire de Neurobiologie. Life Sciences Research Unit; Luxemburgo;Fil: Klosptein, Armelle. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;Fil: Kerninon, Christophe. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;Fil: Frah, Magali. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;Fil: Coowar, Djalil. AxoGlia Therapeutics; Luxemburgo;Fil: Baron-van Evercooren, Anne. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;Fil: Morga, Eleonora. Université du Luxembourg. Faculté des Sciences, de la Technologie et de la Communication. Laboratoire de Neurobiologie. Life Sciences Research Unit; Luxemburgo;Fil: Heuschling, Paul. Université du Luxembourg. Faculté des Sciences, de la Technologie et de la Communication. Laboratoire de Neurobiologie. Life Sciences Research Unit; Luxemburgo;Fil: Nait Oumesmar, Brahim. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;Society for Neuroscience2013-07-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/1723Blanchard, Benoit; Heurtaux, Tony; Garcia, Corina Ileana; Moll, Natalia M.; Caillava, Céline; et al.; Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis; Society for Neuroscience; Journal of Neuroscience; 33; 28; 10-7-2013; 11633-116420270-64741529-2401enginfo:eu-repo/semantics/altIdentifier/doi/doi:10.1523/JNEUROSCI.0774-13.2013info:eu-repo/semantics/altIdentifier/url/http://www.jneurosci.org/content/33/28/11633.full.pdf+htmlinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:49:09Zoai:ri.conicet.gov.ar:11336/1723instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:49:09.562CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis
title Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis
spellingShingle Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis
Blanchard, Benoit
Tfa-12
Oligodendrocytes
Multiple Sclerosis
Myelin
title_short Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis
title_full Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis
title_fullStr Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis
title_full_unstemmed Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis
title_sort Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis
dc.creator.none.fl_str_mv Blanchard, Benoit
Heurtaux, Tony
Garcia, Corina Ileana
Moll, Natalia M.
Caillava, Céline
Grandbarbe, Luc
Klosptein, Armelle
Kerninon, Christophe
Frah, Magali
Coowar, Djalil
Baron-van Evercooren, Anne
Morga, Eleonora
Heuschling, Paul
Nait Oumesmar, Brahim
author Blanchard, Benoit
author_facet Blanchard, Benoit
Heurtaux, Tony
Garcia, Corina Ileana
Moll, Natalia M.
Caillava, Céline
Grandbarbe, Luc
Klosptein, Armelle
Kerninon, Christophe
Frah, Magali
Coowar, Djalil
Baron-van Evercooren, Anne
Morga, Eleonora
Heuschling, Paul
Nait Oumesmar, Brahim
author_role author
author2 Heurtaux, Tony
Garcia, Corina Ileana
Moll, Natalia M.
Caillava, Céline
Grandbarbe, Luc
Klosptein, Armelle
Kerninon, Christophe
Frah, Magali
Coowar, Djalil
Baron-van Evercooren, Anne
Morga, Eleonora
Heuschling, Paul
Nait Oumesmar, Brahim
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Tfa-12
Oligodendrocytes
Multiple Sclerosis
Myelin
topic Tfa-12
Oligodendrocytes
Multiple Sclerosis
Myelin
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Multiple sclerosis (MS) is an inflammatory disease of the CNS that is associated with demyelination and axonal loss, resulting in severe neurological handicap. Current MS therapies mostly target neuroinflammation but have only a little impact on CNS myelin repair. Progress toward treatments that enhance remyelination would therefore represent major advances in MS treatment. Here, we examined the ability of TFA-12, a new synthetic compound belonging to tocopherol long-chain fatty alcohols, to promote oligodendrocyte regeneration and remyelination in experimental models of MS. We showed that TFA-12 significantly ameliorates neurological deficit and severity of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE) in mice. Histological evaluation of mouse EAE spinal cords showed that TFA-12 treatment reduces inflammation, astrogliosis, and myelin loss. Additionally, we demonstrated that TFA-12 accelerates remyelination of focal demyelinated lesions induced by lysolecithin injections.Wealso found that this compound induces the differentiation of oligodendrocyte precursor cells into mature oligodendrocytes through the inhibition of the Notch/Jagged1 signaling pathway. Altogether, our data provide important proof of principle indicating that TFA-12 could be a potential therapeutic compound for myelin repair in MS.
Fil: Blanchard, Benoit. Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia; . Institut National de la Santé et de la Recherche Médicale; Francia
Fil: Heurtaux, Tony. Université du Luxembourg. Faculté des Sciences, de la Technologie et de la Communication. Laboratoire de Neurobiologie. Life Sciences Research Unit; Luxemburgo;
Fil: Garcia, Corina Ileana. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Farmacología. Cátedra de Química Medicinal; Argentina. Institut National de la Santé et de la Recherche Médicale; Francia. Universite Pierre et Marie Curie; Francia;
Fil: Moll, Natalia M.. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;
Fil: Caillava, Céline. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;
Fil: Grandbarbe, Luc. Université du Luxembourg. Faculté des Sciences, de la Technologie et de la Communication. Laboratoire de Neurobiologie. Life Sciences Research Unit; Luxemburgo;
Fil: Klosptein, Armelle. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;
Fil: Kerninon, Christophe. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;
Fil: Frah, Magali. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;
Fil: Coowar, Djalil. AxoGlia Therapeutics; Luxemburgo;
Fil: Baron-van Evercooren, Anne. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;
Fil: Morga, Eleonora. Université du Luxembourg. Faculté des Sciences, de la Technologie et de la Communication. Laboratoire de Neurobiologie. Life Sciences Research Unit; Luxemburgo;
Fil: Heuschling, Paul. Université du Luxembourg. Faculté des Sciences, de la Technologie et de la Communication. Laboratoire de Neurobiologie. Life Sciences Research Unit; Luxemburgo;
Fil: Nait Oumesmar, Brahim. Institut National de la Santé et de la Recherche Médicale; . Universite Pierre et Marie Curie; Francia; . Centre National de la Recherche Scientifique. Unités Mixtes de Recherche; Francia;
description Multiple sclerosis (MS) is an inflammatory disease of the CNS that is associated with demyelination and axonal loss, resulting in severe neurological handicap. Current MS therapies mostly target neuroinflammation but have only a little impact on CNS myelin repair. Progress toward treatments that enhance remyelination would therefore represent major advances in MS treatment. Here, we examined the ability of TFA-12, a new synthetic compound belonging to tocopherol long-chain fatty alcohols, to promote oligodendrocyte regeneration and remyelination in experimental models of MS. We showed that TFA-12 significantly ameliorates neurological deficit and severity of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE) in mice. Histological evaluation of mouse EAE spinal cords showed that TFA-12 treatment reduces inflammation, astrogliosis, and myelin loss. Additionally, we demonstrated that TFA-12 accelerates remyelination of focal demyelinated lesions induced by lysolecithin injections.Wealso found that this compound induces the differentiation of oligodendrocyte precursor cells into mature oligodendrocytes through the inhibition of the Notch/Jagged1 signaling pathway. Altogether, our data provide important proof of principle indicating that TFA-12 could be a potential therapeutic compound for myelin repair in MS.
publishDate 2013
dc.date.none.fl_str_mv 2013-07-10
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/1723
Blanchard, Benoit; Heurtaux, Tony; Garcia, Corina Ileana; Moll, Natalia M.; Caillava, Céline; et al.; Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis; Society for Neuroscience; Journal of Neuroscience; 33; 28; 10-7-2013; 11633-11642
0270-6474
1529-2401
url http://hdl.handle.net/11336/1723
identifier_str_mv Blanchard, Benoit; Heurtaux, Tony; Garcia, Corina Ileana; Moll, Natalia M.; Caillava, Céline; et al.; Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis; Society for Neuroscience; Journal of Neuroscience; 33; 28; 10-7-2013; 11633-11642
0270-6474
1529-2401
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/doi:10.1523/JNEUROSCI.0774-13.2013
info:eu-repo/semantics/altIdentifier/url/http://www.jneurosci.org/content/33/28/11633.full.pdf+html
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Society for Neuroscience
publisher.none.fl_str_mv Society for Neuroscience
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842268956462678016
score 13.13397